Total Autologous Angiogenic Therapy with Cultured Bone Marrow Derived Mesenchymal Stromal Cells Grown in Platelet-Rich Plasma Against Peripheral Arterial Disease. - Advanced Medical Care
Not Applicable
Recruiting
- Conditions
- Peripheral arterial disease
- Registration Number
- JPRN-jRCTb030210146
- Lead Sponsor
- Fukuda Shoji
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
# Patients with Severe PAD (Peripheral Arterial Disease)
# 20<= Age <=80
# informed consent
Exclusion Criteria
# A past 3 months or current history of alcoholism or drug dependence
# A past 5 years or current history of malignant disease
# Untreated diabetic retinopathy
# No informed consent
# Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method